We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $256M
1-Year Est. Return 25.01%
This Fund
S&P 500
This Quarter Est. Return
+5.26%
1 Year Est. Return
+25.01%
3 Year Est. Return
+86.3%
5 Year Est. Return
+113.69%
10 Year Est. Return
+471.75%
AUM
$24B
AUM Growth
+$1.05B
Cap. Flow
-$221M
Cap. Flow %
-0.92%
Top 10 Hldgs %
13.73%
Holding
1,494
New
103
Increased
612
Reduced
406
Closed
115

Top Buys

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$114M
2
AET
Aetna Inc
AET
+$96.3M
3
TRV icon
Travelers Companies
TRV
+$94.5M
4
CHK
Chesapeake Energy Corporation
CHK
+$89M
5
AEE icon
Ameren
AEE
+$69.4M

Top Sells

Rank Stock Value
1
DB icon
Deutsche Bank
DB
+$247M
2
VZ icon
Verizon
VZ
+$186M
3
MDT icon
Medtronic
MDT
+$150M
4
LO
LORILLARD INC COM STK
LO
+$126M
5
JCI icon
Johnson Controls International
JCI
+$104M

Sector Composition

Rank Sector Weight
1 Healthcare 14.98%
2 Technology 14.23%
3 Financials 12.72%
4 Industrials 11.05%
5 Energy 8.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OCR
1451
DELISTED
OMNICARE INC
OCR
– –
-341,626
Closed -$20.4M
ROSE
1452
DELISTED
ROSETTA RESOURCES INC
ROSE
– –
-7,000
Closed -$326K
DRC
1453
DELISTED
DRESSER-RAND GROUP INC
DRC
– –
-59,746
Closed -$3.49M
PL
1454
DELISTED
PROTECTIVE LIFE CORP
PL
– –
-2,470
Closed -$130K
TIBX
1455
DELISTED
TIBCO SOFTWARE INC
TIBX
– –
-167,000
Closed -$3.39M
END
1456
DELISTED
ENDEAVOUR INTERNATIONAL CORP NEW (NV)
END
– –
-14,300
Closed -$46K
ARX
1457
DELISTED
Aeroflex Holding Corp (DE)
ARX
– –
-5,800
Closed -$48K
QCOR
1458
DELISTED
QUESTCOR PHARMA INC
QCOR
– –
-133,015
Closed -$8.64M
HITT
1459
DELISTED
HITTITE MICROWAVE CORP
HITT
– –
-71,000
Closed -$4.48M
FRX
1460
DELISTED
FOREST LABORATORIES INC
FRX
– –
-117,981
Closed -$10.9M
EPL
1461
DELISTED
EPL OIL & GAS, INC COMMON STK
EPL
– –
-18,300
Closed -$706K
ARTC
1462
DELISTED
ARTHROCARE CORP
ARTC
– –
-95,730
Closed -$4.61M
BEAM
1463
DELISTED
BEAM INC COM STK (DE)
BEAM
– –
-217,769
Closed -$18.1M
KFN
1464
DELISTED
KKR FINANCIAL HOLDINGS LLC COM
KFN
– –
-39,100
Closed -$452K
TECUA
1465
DELISTED
TECUMSEH PRODUCTS CO CL-A
TECUA
– –
-90,518
Closed -$625K
LNKD
1466
DELISTED
LinkedIn Corporation
LNKD
– –
-500
Closed -$92K
ANK
1467
DELISTED
ATLANTIC TELE-NETWORK,INC
ANK
– –
-6,431
Closed -$424K
55 56 57 58
59

Similar funds

PHAM
Palisades Hudson Asset Management Fort Lauderdale, Florida $257M AUM 21.62% 1-Year Est. Return
HFRG
Houlihan Financial Resource Group Ashburn, Virginia $257M AUM 14.19% 1-Year Est. Return
EBWM
Eagle Bluffs Wealth Management Columbia, Missouri $257M AUM 30.19% 1-Year Est. Return
GCCM
Gate City Capital Management Chicago, Illinois $257M AUM 37.12% 1-Year Est. Return
CIA
Corigliano Investment Advisers Raleigh, North Carolina $256M AUM 54.89% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
ACM
ADW Capital Management Miami Beach, Florida $257M AUM 11.22% 1-Year Est. Return
CCA
Cruiser Capital Advisors Stamford, Connecticut $257M AUM 65.27% 1-Year Est. Return

Axa's Q2 2014 Portfolio in Review

As of Q2 2014, Axa held 1,494 positions worth $24B, up 4.6% from $23B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Axa's Q2 2014 filing shows 103 new, 612 increased, 406 reduced and 115 closed positions. Its largest new stake was Boston Scientific: 4,394,250 shares worth $56.1M. The largest sale was Deutsche Bank, an estimated $247M.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 15% a quarter earlier, followed by Technology and Financials.

  • Axa's largest Q2 2014 buy was Boston Scientific: 4,394,250 shares worth $56.1M.
  • Axa added most to Gilead Sciences in Q2 2014, an estimated $114M increase.
  • Axa's biggest Q2 2014 reduction was Deutsche Bank, cutting an estimated $247M.
  • Axa fully exited OMNICARE INC in Q2 2014, selling an estimated $20.4M.
  • Axa's ten largest holdings make up 14% of its $24B portfolio in Q2 2014.
  • Axa opened 103 new positions and closed 115 in Q2 2014.
  • Axa's portfolio value rose 4.6% quarter-over-quarter to $24B.

Based on Axa's 13F filing for Q2 2014, filed 13 Aug 2014.